Non-traditional risk factors for atherosclerosis

Area of Science:

• Cardiovascular Medicine
• Biochemistry
• Clinical Pathology

Background:

• Atherosclerosis risk assessment traditionally relies on established factors.
• Emerging research has identified several non-traditional markers associated with cardiovascular disease.
• These markers offer potential for improved risk stratification and understanding of disease mechanisms.

Purpose of the Study:

• To review and analyze non-traditional risk factors for atherosclerosis.
• To evaluate the evidence supporting the role of these markers in cardiovascular disease.
• To discuss their potential clinical utility and impact on future therapeutic strategies.

Main Methods:

• Literature review of studies identifying non-traditional risk markers for atherosclerosis.
• Analysis of markers related to lipoprotein metabolism, endothelial dysfunction, hemostasis, and inflammation.
• Assessment of the evidence supporting the clinical acceptance of these markers.

Main Results:

• Lipoprotein (a), homocysteine, fibrinogen, and C-reactive protein are identified as key non-traditional risk markers.
• These markers are linked to an increased risk of cardiovascular disease and premature atherosclerotic disease.
• Evidence supports their role in enhancing the predictive value of established risk factors.

Conclusions:

• Non-traditional risk markers significantly contribute to identifying individuals at high risk for atherosclerotic cardiovascular disease.
• These markers enhance the understanding of atherosclerosis pathophysiology.
• Their integration into clinical practice may refine therapeutic decisions for cardiovascular disease prevention.